Loading...
patent
Ccr7 ligand delivery and co-delivery in immunotherapy
2017
Chemokines may be administered to a patient for immunotolerization. Chemokines include CCL19 and CCL21. Materials and methods for accomplishing tolerization and described.
Type
patent
EPO Family ID
44368436
Inventors
Note
Alternative title(s) : (de) Ccr7-liganden-verabreichung und co-verabreichung in einer immuntherapie (fr) Administration et co-administration de ligands de ccr7 en immunothérapie
TTO classification
TTO:6.0944
Patent number | Country code | Kind code | Date issued |
EP2547328 | EP | B1 | 2017-06-07 |
EP2547328 | EP | A4 | 2014-03-05 |
US8592364 | US | B2 | 2013-11-26 |
EP2547328 | EP | A2 | 2013-01-23 |
WO2011100460 | WO | A3 | 2011-12-08 |
US2011206759 | US | A1 | 2011-08-25 |
WO2011100460 | WO | A2 | 2011-08-18 |
Available on Infoscience
June 13, 2017
Use this identifier to reference this record